CSI Market
Sign In | Register

Novo Nordisk A (NVO) Annual Balance Sheets

Annual · GAAP · USD millions
Access NVO quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Novo Nordisk A finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash, Cash Equivalents Other4,158.39
Current Tax Assets Current4,848.00
Cash & Short-term Investments9,006.00
Accounts receivable11,133.88
Inventories761.79
Inventories7,797.45
Other Current Assets47,126.00
Total Current Assets27,098.21
Equipment/Property/Plant Net0.00
Goodwill net3,118.32
Intangible Assets17,317.41
Deferred Tax Assets3,715.74
Other Assets, Noncurrent326,957.00
Current Prepayments And Other Current Assets13,482.00
Current Derivative Financial Assets6,682.00
Balances With Banks26,464.00
Other Receivables And Prepayments Noncurrent-
Other Noncurrent Financial Assets-
Noncurrent Assets366.00
Total Assets85,308.30
Liabilities
Short-term Debt20,577.94
Other Liabilities, Current96,346.00
Current Provisions58.77
Total Current Liabilities33,887.65
Long-term debt0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI1,038.81
Noncurrent Provisions126,583.00
Trade And Other Current Payables To Trade Suppliers19,758.00
Current Tax Liabilities Current8,416.00
Other Current Liabilities39,721.00
Current Derivative Financial Liabilities2,026.00
Noncurrent Recognised Liabilities Defined Benefit Plan861.00
Noncurrent Liabilities133,194.00
Total Liabilities54,816.94
Stockholders' Equity
Other Equity194,047.00
Common Stockholder's Equity194,047.00
Total Stockholder's Equity30,491.36
Liabilities & Stockholder's Equity85,308.30
4 historic quarters locked

Sign in to unlock the full Novo Nordisk A balance sheet history.

Sign In Create Free Account

About Novo Nordisk A S Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 4, 2026
  • Source: nvo-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000353278-26-000012

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License